Holder Capital Partners - Executive Summary

Holder Capital Partners (“HCP”) was formed for the express purpose of assisting historically “under-funded” segments of the healthcare industry, namely companies in healthcare services information technology, clinical diagnostics and devices, where true cost-reduction objectives can be achieved. As part of the healthcare service category, we will also invest in companies that aid in the infrastructure and other mechanisms necessary to deliver biotech solutions. Often the companies in these target segments lack the funding and management resources to succeed. In addition, the convergence of healthcare and technology is finally at an inflection point creating unparalleled opportunities not seen before and that will extend into the indefinite future.

HCP represents the formalization of a body of work that extends back to early as 1980. Together the members bring a combined set of professional abilities, a proven track record and significant domain expertise in these healthcare segments unique to the traditional venture consulting partnership. This multi-disciplinary approach includes significant expertise in the areas of management and financial operations; strategic alliances; executive recruiting; investment analysis and funding; technology analysis, development and deployment and sales.

With over 60 years combined experience in the healthcare industry, and cross-related experience working together with over 20 companies at various stages of development, the HCP team believes its core capabilities and contacts at the most senior levels of the healthcare industry are imperative to sourcing and validating opportunities, and to the successful growth and profitability of companies in these segments of healthcare. By being proactive with the companies it chooses to become involved with, their management teams and in the boardroom, HCP enables these companies to achieve rapid growth, profitability, and ultimate liquidity in record time.

HCP is and has been instrumental in the creation of several new industries. The historical examples are: the provision of IV therapies in alternate care settings (Caremark); an ATM model for dispensing drugs and supplies in patient care settings (Pyxis); the first widely used ambulatory pump for infusion therapies (Pancretec) and the first nationwide all digital information management company servicing management groups and hospitals with their dictation and transcription needs (EDiX). We presently see a number of new emerging industries on the horizon.





	Holder Capital Partners (“HCP”) was formed for the express purpose of assisting historically “under-funded” segments of the healthcare industry, namely companies in healthcare services information technology, clinical diagnostics and devices, where true cost-reduction objectives can be achieved. As part of the healthcare service category, we will also invest in companies that aid in the infrastructure and other mechanisms necessary to deliver biotech solutions. Often the companies in these target segments lack the funding and management resources to succeed. In addition, the convergence of healthcare and technology is finally at an inflection point creating unparalleled opportunities not seen before and that will extend into the indefinite future. HCP represents the formalization of a body of work that extends back to early as 1980. Together the members bring a combined set of professional abilities, a proven track record and significant domain expertise in these healthcare segments unique to the traditional venture consulting partnership. This multi-disciplinary approach includes significant expertise in the areas of management and financial operations; strategic alliances; executive recruiting; investment analysis and funding; technology analysis, development and deployment and sales. With over 60 years combined experience in the healthcare industry, and cross-related experience working together with over 20 companies at various stages of development, the HCP team believes its core capabilities and contacts at the most senior levels of the healthcare industry are imperative to sourcing and validating opportunities, and to the successful growth and profitability of companies in these segments of healthcare. By being proactive with the companies it chooses to become involved with, their management teams and in the boardroom, HCP enables these companies to achieve rapid growth, profitability, and ultimate liquidity in record time. HCP is and has been instrumental in the creation of several new industries. The historical examples are: the provision of IV therapies in alternate care settings (Caremark); an ATM model for dispensing drugs and supplies in patient care settings (Pyxis); the first widely used ambulatory pump for infusion therapies (Pancretec) and the first nationwide all digital information management company servicing management groups and hospitals with their dictation and transcription needs (EDiX). We presently see a number of new emerging industries on the horizon.



	© 2006 Holder Capital Partners. All rights reserved. Holder Capital Partners and HCP are servicemarks of Holder Capital Partners LLP. This website is best viewed in Internet Explorer 5.0 or higher and Netscape Navigator 6.0 or higher. This website, the material it contains and any information you may submit are subject to certain terms of use and conditions, and Holder Capital Partners LLP privacy policy.